Skip to main content
Caplight Logo









dxOmics

dxOmics

Private
TübingenHealthcare & Life Scienceshttps://dxomics.de/

Last Round

Grant

Jul 17, 2025

Total Funding Raised

$2,000

Company Overview

dxOmics is a biotechnology company that provides an AI-driven, cloud-enabled clinical decision support system for genome diagnostics and research, facilitating NGS analysis, interpretation of genetic variants, and report generation for rare genetic diseases and cancer.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Precision Medicine, Healthcare Analytics, Biotechnology, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

clinical decision support systemgenomic data analysisNGS data analysisdiagnostic AICDSSvariant interpretationrare disease diagnosticscancer genomicsprecision medicinebioinformatics softwaregenomic medicinemulti-omics analysison-premise deploymentcommercial open source

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

dxOmics Comparables

Compare dxOmics with similar companies based on industry and business-model similarity.

dxOmics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Limbus Medical Technologies
81%
SeqOne
78%
Saphetor
77%

dxOmics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 17, 2025
AcceleratorJun 24, 2025
GrantJun 3, 2025

Key People

Founding team and executive leadership

Daniela Bezdan

Co-Founder CEO DxOmics GmbH

Founding Team

dxOmics Investors

Notable investors and investment history

dxOmics investors
InvestorRounds
L-BankGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 17, 2025

    Received grant funding.

  • Jun 3, 2025

    $2K grant round led by L-Bank.

dxOmics Filings

Explore SEC and related filing metadata, where available.

dxOmics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about dxOmics's valuation, stock price, and market status.

Is dxOmics a public or private company?

dxOmics is a private company.

What is the current stock price of dxOmics?

dxOmics is a private company with no public stock price. No recent secondary market data is available.

How much is dxOmics worth (valuation)?

Valuation information for dxOmics is not publicly available.

Can I buy dxOmics stock?

dxOmics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was dxOmics's last funding round?

dxOmics's most recent funding round was Grant on July 17, 2025.

Who are the main investors in dxOmics?

Key investors in dxOmics include L-Bank.

Will dxOmics IPO soon?

No public IPO plans have been announced for dxOmics.

How can I track dxOmics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor dxOmics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTübingen
Employee Range1
Year Founded2024
Last FundingJul 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?